pharmadrug

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) Q2 2022 total revenue was CA$4.5 million ($3.45 million), up 60% year-over-year, driven by growth in the medical cannabis segment in Colombia and the United Kingdom. The decrease of 4% in total revenue for Q2 2022 compared to...

Pharmaceutical company PharmaDrug Inc. (PINK: LMLLF) — which focuses on cannabis, psychedelics and naturally-derived medicines — has launched a sponsored research agreement with the University of Michigan to study the psychedelic DMT. The research will be led by Dr. Jimo...

Mind Cure Closes $18M Raise Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million) offering. The company issued approximately 38 million units, consisting of one share and one half of a share purchase warrant, at CA$0.60 per unit.  The proceeds...

Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) has agreed to acquire Super Smart, a Netherlands startup geared toward psychedelics. Terms of the deal were not disclosed. Toronto-based Pharmadrug announced Wednesday it has entered into a non-binding letter of intent with Interrobang Ltd., which...